Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A4 | P26447 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | GCGR | P47871 | 1/20 | 0.30 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.30 |
| ▸ | PDE7B | Q9NP56 | 2/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31223185 | 1.00 | S100A4 (0.36) | S100A4GPR3NPBWR1PDK2CHEK1 | |
| SCHEMBL24588652 | 0.85 | S100A4 (0.47) | S100A4GPR3PDK2SMN1; SMN2HSD11B1 | |
| SCHEMBL14951394 | 0.81 | MAPK1 (0.41) | GAASMN1; SMN2HSD11B1 | |
| SCHEMBL21937508 | 0.77 | PTPRC (0.36) | PDK2GAASMN1; SMN2HSD11B1 | |
| SCHEMBL31223191 | 0.77 | PTPRC (0.36) | PDK2GAASMN1; SMN2HSD11B1 | |
| SCHEMBL28602950 | 0.77 | TSHR (0.34) | SMN1; SMN2 | |
| SCHEMBL17068901 | 0.77 | S100A4 (0.47) | S100A4GPR3PDK2CHEK1SMN1; SMN2 | |
| SCHEMBL31674872 | 0.77 | S100A4 (0.47) | S100A4GPR3PDK2CHEK1SMN1; SMN2 | |
| SCHEMBL30968565 | 0.77 | S100A4 (0.47) | S100A4GPR3PDK2CHEK1SMN1; SMN2 | |
| SCHEMBL31465791 | 0.75 | S100A4 (0.50) | S100A4GPR3PDK2CHEK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12091403-B2 | Compound for organic electric element, organic electric element using same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-09-17 | — | — | US | disclosed |
| EP-3764416-B1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO LTD (KR) | 2022-01-26 | — | — | EP | disclosed |
| US-20210380568-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD (KR) | 2021-12-09 | — | — | US | disclosed |
| US-20210380568-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD (KR) | 2021-12-09 | — | — | US | disclosed |
| US-20210013420-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
| EP-3764416-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | Duk San Neolux Co., Ltd. (KR) | 2021-01-13 | — | — | EP | disclosed |
| WO-2020085797-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2020-04-30 | — | — | WO | disclosed |
| WO-2020085797-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2020-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210013420-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | S100A4 1436/4885GPR3 4543/4885NPBWR1 4860/4885 |
| US-20210380568-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, VDAC2 | S100A4 1527/4885GPR3 4843/4885NPBWR1 4881/4885 |
| US-12091403-B2 | Compound for organic electric element, organic electric element using same, and electronic device thereof | PIEZO1, ORAI2, VDAC2 | S100A4 1527/4885GPR3 4843/4885NPBWR1 4881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.